Table 1.
Baseline characteristic of the 327 enrolled patients.
| Baseline characteristics | All (n = 327) | No sICH (n = 300) | sICH(n = 27) | p-Value |
|---|---|---|---|---|
| Age, years, mean (SD) | 68.9 (12.1) | 68.6 (12.1) | 72.2 (11.5) | 0.142 |
| Male, n (%) | 190 (58.1) | 175 (58.3) | 15 (55.6) | 0.779 |
| Time OT, min, mean (SD) | 163.5 (75.7) | 164.3 (78.3) | 154.8 (35.8) | 0.534 |
| NIHSS, median (IQR) | 11 (7–16) | 11 (7–16) | 15 (9–20) | 0.057 |
| Glucose, mg/dl, mean (SD) | 129.2 (47.9) | 130.0 (48.7) | 133.2 (38.8) | 0.735 |
| Hypertension, n (%) | 197 (61.0) | 181 (60.9) | 16 (61.5) | 0.952 |
| Diabetes, n (%) | 50 (15.4) | 46 (15.5) | 4 (14.8) | 0.926 |
| Hyperlipidemia, n (%) | 81 (25.8) | 74 (25.6) | 7 (28.0) | 0.793 |
| Atrial fibrillation, n (%) | 73 (22.7) | 68 (23.1) | 5 (18.5) | 0.590 |
| Congestive heart failure, n (%) | 35 (10.9) | 31 (10.5) | 4 (15.4) | 0.440 |
| Aspirin | 105 (32.4) | 92 (31.0) | 13 (48.1) | 0.068 |
| Other antiplatelets | 36 (11.1) | 32 (10.8) | 4 (14.8) | 0.522 |
| Antihypertensives | 168 (51.7) | 152 (51.0) | 16 (59.3) | 0.411 |
| Statins | 31 (9.5) | 29 (9.7) | 2 (7.4) | 0.701 |
| Recent infection or inflammation, n (%) | 43 (13.2) | 41 (13.7) | 2 (7.7) | 0.388 |
sICH, symptomatic intracerebral hemorrhage.
*p calculated by Mann–Whitney U test for NIHSS, by ANOVA for other numeric variables, by Pearson χ2 for categorical variables.